Experience with long-acting hormonal implants for contraception in a German gynecological private practice
Hoffmann, K.O.K.
Advances in Contraception 11(1): 10
1995
ISSN/ISBN: 0267-4874 Document Number: 210608
Document emailed within 1 workday
Related Documents
Batur, P.; Sikka, S.; McNamara, M. 2018: Contraception Update: Extended Use of Long Acting Methods, Hormonal Contraception Risks, and Over the Counter Access Journal of Women's Health 27(12): 1437-1440Batur, P.; Sikka, S.; McNamara, M. 2018: Contraception Update: Extended Use of Long Acting Methods, Hormonal Contraception Risks, and Over the Counter Access Journal of Women's Health 27(12): 1437-1440
Wu, L.; Janagam, D.R.; Mandrell, T.D.; Johnson, J.R.; Lowe, T.L. 2015: Long-acting injectable hormonal dosage forms for contraception Pharmaceutical Research 32(7): 2180-2191
2012: Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices Obstetrics and gynecology 120(4): 983-988
2012: Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices Obstetrics and gynecology 120(4): 983-988
Anderson, R.A.; Kinniburgh, D.; Baird, D.T. 2002: Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception Journal of Clinical Endocrinology and Metabolism 87(8): 3640-3649
Belsey, E.M. 1991: Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation Advances in contraception: the official journal of the Society for the Advancement of Contraception 7(2-3): 257-270
Belsey, E.M. 1991: Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation Advances in contraception: the official journal of the Society for the Advancement of Contraception 7(2-3): 257-270
Pace, L.E.; Dolan, B.M.; Tishler, L.W.; Gooding, H.C.; Bartz, D. 2016: Incorporating Long-acting Reversible Contraception into Primary Care: a Training and Practice Innovation Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health 26(2): 131-134
Bitzer, J.; Kunz, J. 2000: Contraception from the viewpoint of women (2): Long-term pill users are especially pleased by the advantages of hormonal contraception. Comprehensive study of motives at first and refill prescription of the pill and evaluation after 3 months of hormonal contraception Praxis 89(31-32): 1237-1242
Bitzer, J.; Kunz, J. 2000: Contraception from the viewpoint of women (2): Long-term pill users are especially pleased by the advantages of hormonal contraception. Comprehensive study of motives at first and refill prescription of the pill and evaluation after 3 months of hormonal contraception Praxis 89(31-32): 1237-1242
Bitzer, J.; Kunz, J. 2000: Contraception from the viewpoint of women (2): Long-term pill users are especially pleased by the advantages of hormonal contraception. Comprehensive study of motives at first and refill prescription of the pill and evaluation after 3 months of hormonal contraception Praxis 89(31-32): 1237-1242
Bitzer, J.; Kunz, J. 2000: Contraception from the viewpoint of women (2): Long-term pill users are especially pleased by the advantages of hormonal contraception. Comprehensive study of motives at first and refill prescription of the pill and evaluation after 3 months of hormonal contraception Praxis 89(31-32): 1237-1242
Bitzer, J.; Kunz, J. 2000: Contraception from the viewpoint of women (2): Long-term pill users are especially pleased by the advantages of hormonal contraception. Comprehensive study of motives at first and refill prescription of the pill and evaluation after 3 months of hormonal contraception Praxis 89(31-32): 1237-1242
Emanuel Cardamakis, N A. Georgopoulos, A P. Pappas, A Fotopoulos, G P. Sykiotis, D Vassilios, A. Tzingounis 2001: Clinical Experience with Levonorgestrel Subdermal Implants (Norplant)1 for Long-Term Contraception Clinical Drug Investigation 21(12): 827-834
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Bhatnagar, S.; Srivastava, U.K.; Takkar, D.; Chandra, V.L.; Hingorani, V.; Laumas, K.R. 1975: Long-term contraception by steroid-releasing implants. II. A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in women Contraception 11(5): 505-521
Kroelinger, C.D.; Pagano, H.P.; DeSisto, C.L.; Estrich, C.; Romero, L.; Pliska, E.; Akbarali, S.; Velonis, A.; Cox, S. 2024: Increasing Access to Contraception: Examining Barriers and Facilitators of Long-Acting Reversible Contraception Journal of Women's Health 33(1): 52-61